PTAB Says Sovereign Immunity Traded Away By Filing Infringement Suits in Court

Drug Industry Daily
The PTO’s Patent Trial and Appeal Board dismissed a patent owner’s claims of sovereign immunity from the proceedings — in a move that might have implications for Allergan’s Restasis patent case involving a Native American tribe that is currently pending before the board.

To View This Article:


Subscribe To Drug Industry Daily